Use of thrombin time to transition from dabigatran to intravenous unfractionated heparin in patients with acute kidney injury
American Journal of Health-System Pharmacy · 2025
DOI: 10.1093/ajhp/zxaf059 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Health-System Pharmacy, 2025. Verfasst von Donna Barakeh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA. Hauptthemen laut MEDLINE: Dabigatran, Acute Kidney Injury, Heparin, Antithrombins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Purpose
This case series explores the use of thrombin time (TT) to transition 2 patients from dabigatran to unfractionated heparin (UFH) in the setting of acute kidney injury (AKI) and coagulopathy concerning for dabigatran accumulation. Summary Serial TT monitoring was employed until the value began to trend below 120 seconds, indicating ongoing drug clearance, at which point UFH was initiated. Patient 1 experienced rectal bleeding following initiation of UFH, while patient 2 experienced hemoglobin drops without an apparent bleeding source. No thrombotic events occurred during either hospitalization.
Conclusion
Individualized management remains paramount to balance bleeding and thrombotic risk based on patient-specific factors. Further research is warranted to validate the safety and efficacy of a TT-guided transition strategy and optimize protocols for hospitalized patients transitioning from dabigatran to UFH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA.
- Department of Pharmacy, Houston Methodist Willowbrook Hospital, Houston, TX, USA.
ORCID-Profile: Donna Barakeh
Zitieren
APA
Barakeh, D., Donahue, K. R., Sabawi, M., & Dreucean, D. (2025). Use of thrombin time to transition from dabigatran to intravenous unfractionated heparin in patients with acute kidney injury. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaf059
Vancouver
Barakeh D, Donahue KR, Sabawi M, Dreucean D. Use of thrombin time to transition from dabigatran to intravenous unfractionated heparin in patients with acute kidney injury. American Journal of Health-System Pharmacy. 2025. doi:10.1093/ajhp/zxaf059
BibTeX
@article{Barakeh2025,
author = {Barakeh, Donna and Donahue, Kevin R and Sabawi, Mahmoud and Dreucean, Diane},
title = {Use of thrombin time to transition from dabigatran to intravenous unfractionated heparin in patients with acute kidney injury},
journal = {American Journal of Health-System Pharmacy},
year = {2025},
doi = {10.1093/ajhp/zxaf059}
}
EUVIMED